{"nct_id":"NCT01927341","title":"Phase Ib/II Study of Efficacy and Safety of MEK162 and Panitumumab, in Adult mCRC Patients With Mutant or Wild-type RAS Tumors","status":"COMPLETED","status_verified_date":"2021-01","start_date":"2013-11-19","start_date_type":"ACTUAL","primary_completion_date":"2016-01-25","primary_completion_date_type":"ACTUAL","completion_date":"2016-01-25","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["PFE"]}